- Home
- Publications
- Publication Search
- Publication Details
Title
Antivirals with common targets against highly pathogenic viruses
Authors
Keywords
-
Journal
CELL
Volume 184, Issue 6, Pages 1604-1620
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.cell.2021.02.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation
- (2020) Francesca Curreli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
- (2020) Yong-Zhen Zhang et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
- (2020) Lillian B. Cohn et al. Cell Host & Microbe
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance
- (2020) Francesc Xavier RUIZ et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
- (2020) Tianshu Xiao et al. Nature Chemical Biology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
- (2020) Xiaojie Su et al. Frontiers in Microbiology
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- SnapShot: Enveloped Virus Entry
- (2020) Jason Mercer et al. CELL
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells
- (2020) Qian Wang et al. Science Translational Medicine
- Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2
- (2020) Alex Renn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
- (2020) Rodrigo Jácome et al. Scientific Reports
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Remdesivir: First Approval
- (2020) Yvette N. Lamb DRUGS
- A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
- (2020) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor
- (2020) Yoshiaki Nishimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The place for remdesivir in COVID-19 treatment
- (2020) Barnaby Young et al. LANCET INFECTIOUS DISEASES
- Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study
- (2019) Martin R Gaudinski et al. LANCET
- Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
- (2019) Marina Caskey et al. NATURE MEDICINE
- Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
- (2019) Chang-Yi Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Therapeutic strategies to target the Ebola virus life cycle
- (2019) Thomas Hoenen et al. NATURE REVIEWS MICROBIOLOGY
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
- (2019) Robert N. Kirchdoerfer et al. Nature Communications
- A Structure-Function Diversity Survey of the RNA-Dependent RNA Polymerases From the Positive-Strand RNA Viruses
- (2019) Hengxia Jia et al. Frontiers in Microbiology
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
- (2018) Sangita Venkataraman et al. Viruses-Basel
- De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
- (2018) Chao Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
- (2018) Marhiah C. Montoya et al. mBio
- Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes
- (2018) Longlong Si et al. Science Advances
- An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses
- (2017) David J. Holthausen et al. IMMUNITY
- Influenza antivirals currently in late-phase clinical trial
- (2017) Paulina Koszalka et al. Influenza and Other Respiratory Viruses
- Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
- (2017) Marie Pancera et al. Nature Chemical Biology
- Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
- (2017) Veaceslav Boldescu et al. NATURE REVIEWS DRUG DISCOVERY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Structural Biology of the Zika Virus
- (2017) Yi Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
- (2017) Yufeng Yu et al. Nature Communications
- Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
- (2016) Manu Anantpadma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Hepatitis C virus NS3/4a protease inhibitors
- (2016) John A McCauley et al. CURRENT OPINION IN PHARMACOLOGY
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
- (2016) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor
- (2016) Jian Lei et al. SCIENCE
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
- (2016) R. Kong et al. SCIENCE
- Improving Viral Protease Inhibitors to Counter Drug Resistance
- (2016) Nese Kurt Yilmaz et al. TRENDS IN MICROBIOLOGY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Structural basis for RNA replication by the hepatitis C virus polymerase
- (2015) T. C. Appleby et al. SCIENCE
- Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
- (2015) Auda Eltahla et al. Viruses-Basel
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
- (2014) Lu Lu et al. Nature Communications
- Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance
- (2014) Stéphanie Beaucourt et al. Current Opinion in Virology
- HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
- (2013) Kalyan Das et al. Current Opinion in Virology
- The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
- (2013) Zhilin Ren et al. Protein & Cell
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- The structural biology of HIV-1: mechanistic and therapeutic insights
- (2012) Alan Engelman et al. NATURE REVIEWS MICROBIOLOGY
- Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
- (2011) Hideyuki Ikematsu et al. Expert Review of Anti-Infective Therapy
- Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
- (2011) Emily Happy Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, Synthesis, and Biological Activity of Novel 5-((Arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 Fusion Inhibitors Targeting gp41
- (2010) Shibo Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide
- (2010) W.-G. Forssmann et al. Science Translational Medicine
- An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life
- (2009) D. Xie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2008) F. George Njoroge et al. ACCOUNTS OF CHEMICAL RESEARCH
- The flavivirus polymerase as a target for drug discovery
- (2008) Hélène Malet et al. ANTIVIRAL RESEARCH
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
- (2008) Jeffrey E. Lee et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More